Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers

Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers

Oxidative phosphorylation is an active metabolic pathway in cancer. Atovaquone is an oral medication that inhibits oxidative phosphorylation and is FDA-approved for the treatment of malaria. We investigated its potential anti-cancer properties by measuring cell proliferation in 2D culture. The clini...

Full description

Bibliographic Details
Main Authors: Arvinder Kapur, Pooja Mehta, Aaron D Simmons, Spencer S. Ericksen, Geeta Mehta, Sean P. Palecek, Mildred Felder, Zach Stenerson, Amruta Nayak, Jose Maria Ayuso Dominguez, Manish Patankar, Lisa M. Barroilhet
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
metabolism
oxidative phosphorylation
mitochondria
Online Access:https://www.mdpi.com/2072-6694/14/9/2297

Internet

https://www.mdpi.com/2072-6694/14/9/2297

Similar Items